Clinical Trials Logo

Irreversible Pulpitis clinical trials

View clinical trials related to Irreversible Pulpitis.

Filter by:

NCT ID: NCT04243733 Recruiting - Clinical trials for Irreversible Pulpitis

MTA vs CEM Pulpotomy in Young Permanent Molars

Start date: October 10, 2018
Phase: N/A
Study type: Interventional

The aim of the study The purpose of this present clinical study will be to assess : " the successful clinical outcome of CEM cement in comparison to MTA in the pulpotomy of young permanent molar teeth with irreversible pulpitis . " the successful radiographic outcome of CEM cement in comparison to MTA in the pulpotomy of young permanent molar teeth with irreversible pulpitis.

NCT ID: NCT04157036 Terminated - Clinical trials for Irreversible Pulpitis

Evaluation of Methylprednisolone or Ibuprofen on Efficacy of Nerve Blocks With Symptomatic Irreversible Pulpitis

Start date: February 1, 2020
Phase: Phase 3
Study type: Interventional

This prospective, randomized, double-blind study will compare the effect of oral premedication of ibuprofen and methylprednisolone on the anesthetic efficacy of an Inferior Alveolar Nerve Block (IANB) in adult patients with symptomatic irreversible pulpitis.

NCT ID: NCT04040127 Withdrawn - Clinical trials for Irreversible Pulpitis

Residual Dental Pulp Tissue and Cord Blood Stem Cells

Start date: September 1, 2019
Phase: Phase 2
Study type: Interventional

The experiments outlined in this proposal are designed to test the hypothesis that the in vivo injection of cord blood stem cells (InvitRx®) into the root canal system will facilitate teeth initially diagnosed with irreversible pulpitis, to form normal healthy pulpal tissue.

NCT ID: NCT03749408 Completed - Clinical trials for Irreversible Pulpitis

Effect of Addition of Mannitol to Bupivacaine on IANB Success and Post-endodontic Pain

Start date: December 2012
Phase: Phase 2/Phase 3
Study type: Interventional

Inferior alveolar nerve block using either 0.5% bupivacaine alone or in addittion to mannitol in patients with irreversible pulpitis in mandibular molars.

NCT ID: NCT03415724 Not yet recruiting - Clinical trials for Irreversible Pulpitis

Comparison of Anesthetic Efficacy of Dexmedetomidine and Epinephrine With Lidocaine in Irreversible Pulpitis

Start date: February 1, 2018
Phase: N/A
Study type: Interventional

Aim of the study is to determine and compare the anaesthetic efficacy of dexmedetomidine and epinephrine in combination with 2% lidocaine for inferior nerve block in patients with irreversible pulpitis. Study will be conducted in Post Graduate Institute of Dental Sciences, Rohtak in department of Conservative Dentistry & Endodontics. Vital mature permanent mandibular molars with radiographically exposed dentinal caries and with signs of irreversible pulpitis will be included in the study. The patients will be randomly allocated into two control and two experimental groups and nerve block will be given according to standard protocol.

NCT ID: NCT03186690 Active, not recruiting - Clinical trials for Irreversible Pulpitis

Similar Outcomes of Vital Pulp Therapy Using Mineral Trioxide Aggregate or Biodentine™

Start date: July 4, 2013
Phase: N/A
Study type: Interventional

This study aimed to evaluate the clinical performance of White MTA (MTA, Angelus, Londrina, Brazil) and Biodentine™ in pulp capping of cariously exposed mature permanent teeth. The investigator performed a prospective longitudinal randomized controlled study utilizing vital permanent mature teeth with deep caries. Patients will be divided randomly into Biodentine™ and MTA groups; Teeth will be assessed clinically and radiographically prior to the procedure. Caries will be excavated under local anesthesia, hemostasis is achieved after pulp exposure using NaOCl and will be capped with Biodentine™ or MTA. Clinical and radiographical follow-up will be performed by a blinded calibrated evaluator after six months and one year, and yearly after.

NCT ID: NCT03163420 Active, not recruiting - Clinical trials for Irreversible Pulpitis

Diclofenac Potassium on IANB Efficacy in Symptomatic Irreversible Pulpitis

Start date: July 2016
Phase: Phase 2/Phase 3
Study type: Interventional

The aim of this clinical trial is to evaluate the effect of pre-operative administration of diclofenac potassium on the efficacy of inferior alveolar nerve block on using 2% mepivacaine anaesthetic agent in patients with symptomatic irreversible pulpitis.

NCT ID: NCT03146481 Completed - Clinical trials for Irreversible Pulpitis

Pre-operative Aceclofenac on the Anesthetic Efficacy of IANB in Symptomatic Irreversible Pulpitis

Start date: July 2016
Phase: Phase 2/Phase 3
Study type: Interventional

The aim of this randomized, double-blinded, controlled study is to evaluate the effect of pre-operative oral aceclofenac on the success of the inferior alveolar nerve block with 2% Mepivacaine containing 100,000 Epinephrine for patients with symptomatic irreversible pulpitis.

NCT ID: NCT02981693 Completed - Clinical trials for Apical Periodontitis

Evaluation of iRoot SP as Root Canal Sealer: A Clinical Study

Start date: January 2014
Phase: N/A
Study type: Interventional

The purpose of this study was to evaluate the clinical and radiological outcomes of iRoot SP as a root canal sealer in comparison with AH Plus sealer within 1-year follow up.Patients needing root canal treatment were enrolled and allotted into either iRoot SP group or AH Plus arm randomly. After root canal shaping and cleaning, the teeth were obturated according to their arms. Assessment of postoperative pain was done 1 week after root canal obturation using visual analog scale. After 1-year follow-up, clinical and radiographic evaluations were carried out. Statistical analysis at P < 0.05 was conducted to measure difference between the arms.

NCT ID: NCT02940405 Not yet recruiting - Clinical trials for Irreversible Pulpitis

Ketorolac Premedication for Anesthetic Efficiency of IANB & Postendodontic Pain in Teeth With Irreversible Pulpitis

Start date: January 2017
Phase: N/A
Study type: Interventional

The aim of this study to assess effect of ketorolac premedication on the effectiveness of the inferior alveolar nerve block, pretreatment and postoperative pain in patients with symptomatic irreversible pulpitis.